Tumor size as a prognostic factor in patients with stage IIa colon cancer
-
Published:2018-01
Issue:1
Volume:215
Page:71-77
-
ISSN:0002-9610
-
Container-title:The American Journal of Surgery
-
language:en
-
Short-container-title:The American Journal of Surgery
Author:
Santullo Francesco,
Biondi AlbertoORCID,
Cananzi Ferdinando C.M.,
Fico Valeria,
Tirelli Flavio,
Ricci RiccardoORCID,
Rizzo GianlucaORCID,
Coco Claudio,
Mattana ClaudioORCID,
D'Ugo DomenicoORCID,
Persiani Roberto
Subject
General Medicine,Surgery
Reference35 articles.
1. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;André;N Engl J Med,2004
2. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;André;J Clin Oncol,2009
3. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07;Kuebler;J Clin Oncol,2007
4. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses;Yothers;J Clin Oncol,2011
5. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer;Haller;J Clin Oncol,2011
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献